Haemonetics Ownership | Who Owns Haemonetics?

Overview Forecast RevenueFinancials Chart Transcripts

Haemonetics Ownership Summary

Haemonetics is owned by 108.61% institutional investors, 1.26% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 12.78% of HAE shares. Neuberger Berman Genesis Inv is the top mutual fund, with 4.39% of its assets in Haemonetics shares.

HAE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Haemonetics	108.61%	1.26%	-9.87%
Sector	Healthcare Stocks	244.59%	12.11%	-156.70%
Industry	Medical Device Stocks	52.73%	12.62%	34.65%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	5.91M	12.78%	$443.19M
Blackrock	5.96M	11.73%	$493.00M
Vanguard group	4.76M	10.18%	$381.60M
Neuberger berman group	4.18M	9.04%	$313.47M
Aqr capital management	2.27M	4.90%	$165.02M
Ariel investments	2.06M	4.46%	$154.57M
Vanguard capital management	2.06M	4.46%	$154.47M
State street	1.82M	3.93%	$136.36M
Dimensional fund advisors lp	1.59M	3.43%	$118.89M
Citadel advisors	1.51M	3.27%	$113.26M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Kestrel investment management	97.40K	3.98%	$7.30M
North peak capital management	343.08K	2.86%	$25.73M
Expect equity	41.03K	1.98%	$3.08M
Qsv equity investors	14.03K	1.66%	$1.12M
Ariel investments	2.06M	1.54%	$154.57M
Aristotle capital boston	289.62K	1.46%	$21.72M
Dean capital management	44.97K	1.22%	$3.37M
River road asset management	1.29M	1.07%	$96.42M
Riverwater partners	47.65K	1.06%	$3.57M
Aurora investment counsel	25.50K	0.98%	$1.91M

Top Buyers

Holder	Shares	% Assets	Change
Ariel investments	2.06M	1.54%	2.06M
Citadel advisors	1.51M	0.01%	1.25M
Neuberger berman group	4.18M	0.21%	618.52K
Sixth street partners management company	591.42K	0.01%	591.42K
Millennium management	570.41K	0.02%	560.63K

Top Sellers

Holder	Shares	% Assets	Change
Capital research global investors	-	-	-1.14M
Aqr capital management	2.27M	0.06%	-1.09M
Fmr	288.05K	0.00%	-987.83K
Sg capital management	-	-	-906.89K
Westfield capital management co lp	-	-	-805.92K

New Positions

Holder	Shares	% Assets	Change	Value
Ariel investments	2.06M	1.54%	2.06M	$154.57M
Sixth street partners management company	591.42K	0.01%	591.42K	$44.36M
Glenmede trust co na	204.65K	0.07%	204.65K	$15.35M
Longaeva partners	163.82K	0.27%	163.82K	$12.29M
Norges bank	125.93K	0.00%	125.93K	$10.09M

Sold Out

Holder	Change
Colonial trust co / sc	-1.00
Sound income strategies	-1.00
Rfp financial group	-1.00
Tfc financial management	-1.00
Dunhill financial	-1.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	338	1.81%	50,201,673	5.42%	108	1.02%	163	-6.32%	120	10.09%
Mar 31, 2026	157	-54.62%	14,419,965	-71.66%	30	0.26%	81	-51.20%	50	-63.50%
Dec 31, 2025	236	-24.84%	33,122,441	-35.46%	70	0.62%	108	-32.08%	94	-16.81%
Sep 30, 2025	206	-32.01%	35,258,051	-32.80%	73	0.62%	91	-41.29%	88	-13.73%
Jun 30, 2025	309	-6.93%	54,411,783	0.83%	113	0.98%	158	-12.22%	103	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Neuberger Berman Genesis Inv	2.11M	4.39%	-80.85K
iShares Core S&P Mid-Cap ETF	1.60M	3.51%	49.00
Neuberger Genesis Inv	1.49M	3.28%	270.03K
Vanguard US Total Market Shares ETF	1.60M	3.19%	1.18K
Vanguard MStar Total Stk Mkt Idx Invest	1.45M	3.18%	5.20K
Vanguard Total Stock Mkt Idx Inv	1.44M	3.17%	-40.74K
Vanguard Morn Total Stk Mkt Idx Investor	1.44M	3.17%	-40.74K
iShares Russell 2000 ETF	1.20M	2.64%	-21.31K
Vanguard Small Cap Index	1.04M	2.30%	2.36K
T. Rowe Price US Smlr Cm Eq A USD	1.06M	2.22%	-54.63K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 10, 2025	KROLL MARK W	-	Buy	$98.78K
Jul 26, 2024	Strong Stewart W	President, Global Hospital	Sell	$393.04K
Jul 12, 2024	Lingamneni Anila	EVP, Chief Technology Officer	Sell	$7.11K
Jul 11, 2024	Lingamneni Anila	EVP, Chief Technology Officer	Sell	$192.24K
May 29, 2024	Basil Michelle L	EVP and General Counsel	Sell	$362.61K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	1	-
2025 Q3	-	-
2025 Q2	-	-
2024 Q4	-	-
2024 Q3	-	3

HAE Ownership FAQ

Who Owns Haemonetics?

Haemonetics shareholders are primarily institutional investors at 108.61%, followed by 1.26% insiders and -9.87% retail investors. The average institutional ownership in Haemonetics's industry, Medical Device Stocks, is 52.73%, which Haemonetics exceeds.

Who owns the most shares of Haemonetics?

Haemonetics’s largest shareholders are Blackrock funding, inc. /de (5.91M shares, 12.78%), Blackrock (5.96M shares, 11.73%), and Vanguard group (4.76M shares, 10.18%). Together, they hold 34.69% of Haemonetics’s total shares outstanding.

Does Blackrock own Haemonetics?

Yes, BlackRock owns 11.73% of Haemonetics, totaling 5.96M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 493M$. In the last quarter, BlackRock decreased its holdings by -25.268K shares, a -0.42% change.

Who is Haemonetics’s biggest shareholder by percentage of total assets invested?

Kestrel investment management is Haemonetics’s biggest shareholder by percentage of total assets invested, with 3.98% of its assets in 97.4K Haemonetics shares, valued at 7.3M$.

Who is the top mutual fund holder of Haemonetics shares?

Neuberger Berman Genesis Inv is the top mutual fund holder of Haemonetics shares, with 4.39% of its total shares outstanding invested in 2.11M Haemonetics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools